Publications for Daniel Öhman
Co-author map based on ISI articles 2007-
Journal Articles
Daniel Öhman, Maria Dolores Cherma Yeste, Björn Norlander and Finn Bengtsson
Determination of serum reboxetine enantiomers in patients on chronic medication with racemic reboxetine
Therapeutic Drug Monitoring, 2003, 25(2), 174-182.
Web of Science® Times Cited: 14 |
Daniel Öhman, Björn Norlander, Curt Peterson and Finn Bengtsson
Simultaneous determination of reboxetine and O-desethylreboxetine enantiomers using enantioselective reversed-phase high-performance liquid chromatography
Journal of Chromatography A, 2002, 947(2), 247-254.
Web of Science® Times Cited: 22 |
Love Linner, Hanna Endersz, Daniel Öhman, Finn Bengtsson, Martin Schalling and Torgny Svensson
Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex
Journal of Pharmacology and Experimental Therapeutics, 2001, 297(2), 540-546.
Web of Science® Times Cited: 66 |
Daniel Öhman, Björn Norlander, Curt Peterson and Finn Bengtsson
Bioanalysis of racemic reboxetine and its desethylated metabolite in a therapeutic drug monitoring setting using solid phase extraction and HPLC
Therapeutic Drug Monitoring, 2001, 23(1), 27-34.
Web of Science® Times Cited: 25 |
Daniel Öhman, Björn Norlander and Björn Carlsson
On-line extraction using an alkyl-diol silica precolumn for racemic citalopram and its metabolites in plasma: results compared with solid-phase extraction methodology
Journal of Chromatography B, 2001, 753(2), 365-373.
Web of Science® Times Cited: 36 |
Conference Articles
Ph.D. Theses
Ph.D., Lic. Theses
